A mitogenic substance on murine lymphocytes was detected in the culture supemate of Streptococcus pyogenes type 12 strain. This substance had a molecular weight of 28 000 and p I 9.2, and was designated as S. pyogenes mitogen @PM). The proliferative response of C3H/HeN spleen cells began at 1 ng ml-' and reached a maximal response at 100 ng ml-' of SPM for 4 days culture. Anti-Thyl.2 mAb and complement-treated spleen cells abrogated the proliferative response to any dose of SPM. Although the anti-major histocompatibility complex class I mAbs had no blocking effect on proliferation by SPM, this proliferation was substantially inhibited by the addition of either anti-I-A or anti-I-E mAb, and complete inhibition was produced by the addition of both mAbs. Fixed antigen-presenting cells still induced T cell proliferation by SPM. A significant expansion of 'I' cells bearing VP13 T-cell receptor was observed up to 73% among the Thyl.2+ cells in cultures stimulated with SPM, indicating expansion in a VP-specific manner. Immunoblotting of IEF-separated proteins showed that anti-streptococcal pyrogenic exotoxin (SPE) C reacted with a protein of pI 6.9 and anti-SPEB did not show any reactivity. SPEA was reported to expand VS8.1 and 8.2 bearing murine T cells, and SPM did not. SPM also exhibited potent mitogenic activity on human T cells and VP21 + T cells were selectively expanded. These results lead to the conclusion that SPM was neither SPEA, B nor C, but a new protein belonging to a group of streptococcal superantigens with activity on not only human but also murine lymphocytes.
Introduction
factors associated with scarlet fever, rheumatic fever
Harmful Gram-positive bacteria produce a variety of exoproteins, many of which are toxins or otherwise involved in pathogenicity or virulence. or streptococcal toxic shock-like disease. The excreted streptococcal pyrogenic exotoxins (SPEs) comprise a group of serologically distinct proteins. Three groups of SPEs @PEA, B and C> have been implicated as the causative agents of the disease [l-51 . These toxins are also powerful T cell mitogens, and like other mitogens they cause T cell activation and proliferation [6] .
Recently, SPEs have been characterized as bacterial superantigen [7-121, like staphylococcal enterotoxins @Es) produced by Staphylococcus aureus which are potent mitogens for T cells of several species [11, 13] , with respect that these antigens differ from conventional antigens in the immune response. Common characteristics of these toxins are that they bind to major histocompatibility complex (MHC) class II molecules on antigen-presenting cells (APC) for presentation to T cells directly without processing and selectively stimulate T cells expressing particular VB gene segments within their T-cell receptor (TCR) [ll] . Despite the requirements for class II elements, most superantigens can be presented by allogeneic APC or cells transfected with class II molecule genes regardless of the allotype or isotype. While SPEB is a M, of 42000 proteinase precursor which is activated by cleavage to M, of 30000 proteinase [ 141, its superantigenicity is controversial [lo] . Two novel 5. pyogenes products, the recently identified streptococcal superantigen (SSA) and mitogenic factor (MF) have been identified and reported to exhibit superantigenic activities [ 15,161. Superantigens are powerful oligoclonal mitogens and exotoxin-mediated rapid T cell activation leading to systemic cytokine secretion may be causally linked to the pathogenicity of these bacteria [l-5] . On the other hand, superantigens induce clonal unresponsiveness of T cells expressing reactive VB TCR with in vivo administration, suggesting a possible role of superantigens for particular diseases originating from bacterial infections [17] . Analysis of the mechanism of T cell activation including the repertoire formation and self-tolerance of T cell might be useful not only to clarify the significance of immune response provoked by superantigens, but also to make clear the mechanisms by which superantigens mediate disease.
In the course of investigating superantigenicity of cytoplasmic membrane-associated protein (CAP) from S. pyogenes type 12 strain as recently reported [18, 19] , a mitogenic substance for murine and human lymphocytes, unlike the previously described streptococcal superantigens, was detected in the culture supemate, in which one or more of the toxins are usually produced by more than 90% of S. pyogenes strains [4] . We were interested in the mechanism of T cell activation and the crucial role in pathogenicity for the mitogenic substance. In this paper, details of the purification and characterization of the substance with this mitogenic activity termed Streptococcus pyogenes mitogen @PM) is described.
Materials and methods

Mice
C3H/HeN
and BALB/c mice (6-8 weeks old) were obtained from the Institute of Experimental Animals, Tohoku University School of Medicine and fed under specific pathogen-free condition. SJL/J mice (6-8 weeks old) were purchased from the Funabashi Farm Laboratories (Tokyo, Japan).
Preparation of SPM
S. pyogenes type 12 strain (ATCC 12353) was grown at 37°C in 20 1 of Todd-Hewitt broth (THB) (Oxoid, Hampshire, UK) or THB dialysate medium. After 18 h incubation, the batch culture was continuously centrifuged at 13 000 X g to obtain the culture supemates. SPM from these supemates was precipitated at 60% ammonium sulfate saturation in an ice-bath. The precipitate was dissolved in 20 mM Tris-HCl buffer (pH 7.4) and insoluble substances were removed by centrifugation.
The concentrate was desalted by dialysis against phosphate buffer (0.01 M PB, pH 7.2). The desalted sample was applied to a carboxymethyl (CM) cellulose (Whatman, Maidstone, UK) column (3.5 X 30 cm) equilibrated with 50 mM acetate buffer (pH 5.0). The fractions with mitogenic activity for murine lymphocytes eluted with an acetate buffer containing 0.5 M NaCl were further chromatographed on a column of Sephacryl S-200 Superfine (Pharmacia LKB, Uppsala, Sweden) equilibrated with 10 mM phosphate buffered saline (PBS, pH 7.2). The mitogenic activity was eluted as a major peak M, of 25 000-30 000. The active fractions were pooled and a concentrated sample was applied to Sephadex G-50 column (Pharmacia) [ 181.
Chromatofocusing
The active fractions from a Sephacryl S-200 column were applied to a PBE 118 exchanger (Phar-macia) column (1 X 30 cm) equilibrated with 25 mM triethylamine-HCl buffer (pH 11 .O> and eluted with Pharmalyte (Pharrnacia) with a pH gradient of 8.0-10.5 (1 in 45 dilution) adjusted to pH 8.0 with HCl k31.
SDS-PAGE and isoelectric focusing (IEF)
For molecular weight determination, SDS-PAGE was performed according to the method of Laemmli [20] . The active fractions from the Sephadex G-50 column were loaded, and gels were stained with 0.25% (w/v) Cooma,ssie brilliant blue G (Sigma). Marker proteins (low molecular weight protein kit, Pharmacia) were usedi for the standard. IEF in 5% (w/v) polyacrylamide gels with Pharmalyte range of pH 3-10 was carried out to obtain purified materials and to determine the isoelectric point of SPM [21] . A pl marker protein kit (high pl calibration kit, pH 5-10.5, Pharmacia) was used for the standard.
Cell culture and proliferative assay
Murine spleen cells suspended at 5 X lo5 cells/well in RPM1 1640 medium (Nissui Pharmaceutical Co. Ltd., Tok.yo, Japan) supplemented with 10% (v/v> heat-inactivated foetal calf serum (FCS), 2 mM L-glutamine, and 5 x 10m5 M 2-mercaptoethanol were cultured in the wells of a round-bottomed microtitre plate (Falcon; Becton Dickinson, Lincoln Park, NJ) at 37°C in a humidified atmosphere of 5% CO, in air. Eighteen hours before terminating the culture, each well was pulsed with 0.5 pCi of [3H]TdR and harvested onto a glass fibre filter. Human peripheral blood lymphocytes (PBLs) were isolated from heparinized blood of healthy donors by Ficoll-Isopaque density gradient centrifugation [18, 19] . The isolated PBLs at 1 X lo5 cells/well suspended in RPM1 1640 medium supplemented with 10% (v/v> heat-inactivated autologous serum and 2 mM L-glutamine were cultured as described above. Eight hours before termination, each well was pulsed with 0.5 @i of [3H]TdR. The radioactivity was measured in a liquid scintillation beta counter. The results expressed the mean cpm + S.D. of triplicate cultures [22].
Purification and depletion of T cells
Inguinal lymph nodes from C3H/HeN mice were dissected out and single cell suspensions were prepared. Highly purified T cells were obtained by passage through a nylon wool column [23] . Briefly, a 10 ml plastic syringe was packed with 0.5 g nylon wool (Wako Pure Chemical Industries Ltd., Osaka, Japan), drained with RPM1 1640 medium containing 10% (v/v) FCS, and equilibrated in a 37°C incubator for 60 min. To this column were added 4 to 6 X lo7 lymphocytes in 4 ml medium. The columns were incubated at 37°C for 60 min in a 5% CO, humidified atmosphere. The nonadherent cells were eluted with 10 ml of the warmed medium at a flow rate of 1 drop/s.
These cells were found to be > 98% CD3 positive by analysis on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA) [24] . For depletion of T cells, spleen cells from C3H/HeN mice were treated with anti-Thyl.2 mAb (F7D5, Dainippon Pharmaceutical Inc., Tokyo, Japan) for 60 min at 4°C followed by the addition of 1 in 20 dilution of rabbit complement (C:Low-Tox-M; Cedarlane, Ontario, Canada) for 30 min at 37°C [25] . These cells were < 5% Thyl.2 positive by FACS analysis.
Parafonnaldehyde fixation of APC
Spleen cells from C3H/HeN mice were used as APC. To assess their APC function, the cells were treated with 1% (w/v) paraformaldehyde solution (Wako Pure Chemical Industries Ltd.) in PBS for 15 min at room temperature, washed three times with PBS, and used as fixed APC [26].
Antibodies
Flow cytometric analyses were performed using a FACScan [24] . MAbs used to stain murine lymphocytes were as follows. Anti-mouse CD3 (145-2Cl l), VB2 (B20.6) VP3 &J-25),
VB13 (MR12-3), VB14 (14-2), VB17a (KJ-23) and B220 (RA3-6B2) were purchased from PharMingen (San Diego, CA). L3T4 (GK1.5) and Lyt-2 (53-6.7) were purchased from Becton Dickinson. and Thy 1.2 (F7D5) were purchased from Dainippon Pharmaceutical Inc. All of which were either unconjugated, 
Proliferation of murine spleen cells stimulated with SPM
A specific nature of this exoprotein was its extreme potency to stimulate murine lymphocytes. The product with mitogenic activity from the culture supernate of S. pyogenes type 12 strain was purified by ammonium sulfate precipitation, followed by CM, S-200 and G-50 column chromatographies, and the mitogen was found with an M, of approximately 28 000 as shown by SDS-PAGE analysis, which was designated S. pyogenes mitogen @PM). To determine the optimal conditions required for murine lymphocyte proliferation, SPM preparations were cultured with spleen cells. Results in Fig. 1A show that the mitogenic response of spleen cells began at 1 ng ml-' and reached a maximal response at 100 ng ml-' of SPM, which showed a stronger response than that to SEB. The incubation of spleen cells with SPM (100 ng ml-' ) led to a detectable response on day 2 and to a maximal response on day 4, showing a similar pattern to SEB (Fig. 1B) .
The mitogenicity of SPM was tested on T cells or other lymphocyte subsets. Spleen cells treated with Thyl.2 mAb plus C to remove T cells, which rewere achieved at 10 ng ml-' and higher concentrasulted in < 5% Thyl.2+ cells by FACS analysis, tion. In contrast, anti-Thy1.2 mAb and C treatment were tested for a mitogenic response to SPM stimuof spleen cells abrogates proliferative response to lation. Fig. 2A indicated that proliferative responses any dose of SPM, indicating that SPM is T cell of whole spleen cells treated with C only to SPM mitogen.
lAK - 
Class II-dependent T cell stimulating activity of SPM
To explore whether MHC class II molecules on APC were necessary for T cell stimulating activity of SPM, whole C3H/HeN lymph node cells (> 80% CD3+, > 15% B220+) were passed through a nylon wool column to purify T cells, and purified T cells (> 98% CD3+) were stimulated with SPM. Fig. 2B indicates that SPM has a marked mitogenic activity on whole lymph node cells, whereas there was no mitogenic activity on APC-depleted T cells. Subsequently, we tested the ability of anti-class I or class II antibody to block the SPM-induced proliferative response in spleen cells from C3H/HeN mice. The anti-class I mAbs (anti-K, D) had no blocking effect on SPM-, SEB-or Con A-induced proliferation (data not shown). Fig. 3 shows that SPM-induced proliferation was substantially inhibited by the addition of either anti-I-A or anti-I-E mAb, and better inhibition was observed by adding anti-I-E than anti-I-A mAb. A complete inhibition was performed by addition of 3.0 pg ml-' of both mAbs.
No requirement of processing for the presentation of SPM
To further analyze whether SPM is processed by APC, syngeneic spleen cells were fixed with 1% (w/v) paraformaldehyde for 15 min at room temperature to prevent processing completely [24] , and used as APC. Fig. 4 shows that fixed APC were still effective on induction of T cell proliferation by SPM and SEB.
Specific stimulation of VP13 TCR expressing T cells with SPM
The findings that SPM selectively stimulated murine T cells in a dependent manner on the MHC class II molecules on APC without processing suggest that SPM has properties of a superantigen. To examine whether this mitogen stimulates specific VB TCR bearing T cells, spleen cells from C3H/HeN were cultured with SPM (100 ng ml-i) for 4 days and then the culture was further expanded with 100 U ml-' of IL-2 for 2 days. Cells were harvested and stained with various VP-specific mAbs and Thyl.2 a Spleen cells (5 X lo5 ml-'1 were stimulated with either SPM (50 ng ml-') or SEB (100 ng ml-' ) for 4 days. Cells were then expanded with 100 U ml-' of IL-2 for 2 days and the percentage of Thy-1 + cells expressing each VB was analyzed by flow cytometry. Significant values are in italics.
mAb. The staining results for each of the VP-specific mAb were calculated as a percentage of the total Thyl.2+ cells. As shown in Table 1 , a .significant expansion of T cells bearing VB13 TCR was observed up to 73% among the Thy1.2' cells in cultures stimulated with1 SPM. This enrichment of VB13+ cells was not seen in SEB-or Con A-stimulated cultures, which indicated that expansion of T cells by SPM was in a VB-specific manner and SPM stimulated selectively VB13 TCR bearing murine T cells. In contrast, SEBl selectively stimulated VBS.1 and 8.2 bearing T cells as previously indicated [ 11,131. The observation described above was confirmed with SJL/J mice, lacking VB13 repertoire that responded to SPM [27] . As expected, spleen cells from SJL/J did not show any mitogenic response to SPM (data not shown).
Preferential stimulation of CD4' T cells by
SPA4
Since it was reported that SEB and SPEA induced enormous proliferation of both CD4+ and CD8+ murine T cells, accompanying IL-2 production from T cells [13, 17, 28] , the relative responsiveness of CD4+ and CD8+ T cells against SPM, SEB and Con A was compared using unfractionated C3H/HeN and BALB/c spleen cells. SPM stimulated the CD4+ T cell subset more than the CD8+ T cell subset. For example, the CD4/CD8 ratios of T cells after stimulation with SPM and SEB were 2.09 and 0.91, respectively, suggesting that CD4+ T cells were preferentially activated by SPM stimulation.
Properties of SPM distinct from SPEs
Although this is the first report as to the specific stimulation of murine VB13 expressing T cells by a superantigen produced by S. pyogenes, it is possible that superantigenic properties of SPM resulted from contamination of SPEA, B or C, previously reported as superantigen [7-121. To exclude this possibility, SPM was further characterized by IEF gel. After S. pyogenes type 12 strain was cultured in either standard THB or THB dialysate medium, supernates were purified and loaded on IEF gel. which induced proliferation of VB 13 TCR bearing T cells consists of two proteins (pls 6.9 and 9.2) with similar kZ, each other. In contrast, the supernate from dialysate medium culture, which is the common culture method to obtain SPEs [14, 29, 30] showed only a protein of pl 6.9 (Fig. 5 ) and the supernate, 
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CD3 vZ921 SPM j SPEA SPEC Log Fluorescence Intensity moreover, did not show significant mitogenic activity on murine T cells (data not shown). These results indicated that the isoelectric point of SPM is 9.2, whereas a protein of pl 6.9 is SPEC as previously described [30] . The pl of SPM was confirmed by isoelectric chromatofocusing, suggesting that VB 13 T cell stimulating activity was involved in fractions eluted at pH 9.2 of the column.
Immunoblotting of IEF-separated proteins with anti-SPEB and anti-SPEC antisera showed that anti-SPEC reacted with a protein of pZ 6.9 and anti-SPEB did not show any reactivity (data not shown). SPEA was reported to expand VBS. 1 and 8.2 bearing murine T cells [7, 28] , and SPM did not (Table 1) . Taken together, these results indicate that SPM is a distinct protein from previously reported SPEs.
Proliferation and specific VP21 TCR expression of human T cells in response to SPM
Finally, to determine whether SPM possessed the ability to activate human T cells, human PBLs were stimulated with purified SPM, or with Con A, rS-PEA, and C as control. As demonstrated in Fig. 6A , SPM was also potently mitogenic on human PBLs at concentrations greater than 1 ng ml-', and almost all of the responding cells to SPM were CD3+ T cells, which was the same potential as Con A, rSPEA and C (Fig. 6B) . Furthermore, as far as we examined the VB expression of responding T cells with a series of mAbs by flow cytometry, SPM but not rSPEA or C selectively activated human T cells bearing VP21 in TCR, indicating that SPM exhibits superantigenic activity to human as well as murine T cells. were stimulated with various doses of chromatofocusing purified SPM indicated for 4 days. Bars represent S.D. of the means of triplicate cultures. (B) Human PBLs were cultured with 10 pg ml-' of Con A for 2 days, or 100 ng ml-' of chromatofocussing purified SPM, rSPEA, or C for 3 days followed by expansion with 100 U ml-' of rIL-2 for 2 days. Cells were stained with PE-conjugated anti-CD3 mAb (left column), or anti-VP21 mAb followed by FITC-anti-mouse IgG Ab (right column). After staining, flow cytometric analysis was performed gating responding cells. Numbers within graphs mean percent positive cells.
Discussion
Recently, a new class of T cell mitogen, including several staphylococcall and streptococcal exotoxins, has been successively described [ll] . The mechanisms for immunological recognition of these mitogens, collectively called superantigens, were dictated exclusively by selective VB regions of TCR on T cells via an interaction with MHC class II molecules on APC. A protein SPM with mitogenic activity on both murine and human lymphocytes from culture supernate of S. pyogenes type 12 strain was isolated, and examined for superantigenic activity. First, SPM did not stimulate murine T cells without adherent cells but induced a proliferative response of T cells in the presence of APC (Fig. 2) . Addition of anti-I-A and I-E mAbs which blocked Ia antigen on the surface of APC eliminated the proliferative response induced by SPM (Fig. 31 , which indicated that this response was Ia antigen-dependent.
APC fixed with paraformaldehyde before the assay were still effective in supporting T cell proliferation with SPM, suggesting that processing of SPM by APC was not required for the proliferation of T cells (Fig. 4) . Second, SPM activated selectively VB 13 TCR expressing murine T cells, whereas SEB activated VBS. 1 and 8.2 expressing T cells (Table 1 ) as previously described [11,1.3] . These results led to the conclusion that SPM has all superantigenic properties, resembling a number of bacterial toxins.
S. pyogenes produces extracellular virulence factors including SPEA, B and C, and these were reported to be superantigens [7-121. The superantigenie property of SPEB is now controversial due to possible contamination of VP8 stimulating factor in the preparative materials [lo]. SPEs were described as a more effective mitogen for human and rabbit cells than for murine cells [6, 28] , but SPEA stimulated VBS. 1' and 8.2+ murine T cells in addition to human T cells [7, 28] . We have demonstrated that SPM has strong mitogenic activity eradicated by proteinase K treatment as potent as SEB on murine cells, and stimulates VB13+ T cells but not VBS.l+ or VB8.2+ T cells. SPEA was also reported to be an acidic protein (pZ 5.2) [29], whereas SPM had a pl 9.2 by IEF and chromatofocusing.
These results exclude the possibility of contamination of SPEA with SPM. Gerlach et al. [14] demonstrated that SPEB was a basic protein of pl 9.0 and an i'$ of 30000 with proteinase activity. Western blotting of SPM with anti-SPEB serum did not show any reactivity, which excluded the presence of SPEB. SPEC was reported to be acidic protein of pl 6.7 [30] and IEF analysis in this study, shown in Fig. 5 , suggested that a protein with pZ 6.9 was reactive with anti-SPEC by immunoblotting. SPM was produced from S. pyogenes type 12 strain when cultured in THB, but could not be detected in the supemate from dialysate medium culture commonly used to obtain bacterial virulence factors [ 14, 29, 30] . Therefore, we consider that this may be one of the reasons why the molecular nature of SPM has remained elusive. From all these observations, we concluded that SPM was neither SPEA, B nor C, but a new protein belonging to a group of streptococcal superantigens. Moreover, neither SSA nor MF has been reported to have potential mitogenicity on murine lymphocytes [15, 16] .
SPM purified by chromatofocusing stimulated human PBLs, at concentrations greater than 1 ng ml-', and more than 98% of responding cells to SPM was CD3+ T cells. Furthermore, one of the VB expressions of human T cells stimulated with SPM proved to be VB21+ TCR repertoire by flow cytometry screening. The observation that human SPM-reactive T cells are VP21 + is of interest, and no streptococcal superantigens were reported to stimulate human VP21 + T cells so far. Nucleotide sequence analysis demonstrated 74-76% homology between murine VB13, which are expressed by SPM-reactive murine T cells, and human VP21 [31, 32] . These data demonstrated that SPM is potently superantigenic on murine and human T cells. It is essential to determine the entire amino acid sequence for investigation of fine VB usage, and other characteristics of SPM in more detail. Experiments are now under way to clarify this point.
Several reports suggested that the binding of SEs and SPEA to MHC class II molecules of APC was sufficient to activate CD4+ and CD8+ murine T cells [13, 17, 28] , while response to SPM was primarily mediated by CD4+ T cells at any dose of stimulator, indicating that CD4+ and CD8+ T cells were not equally affected. These observations lead to the hypothesis that SPM has more affinity for the CD4 molecule or other accessory molecules on CD4' T cells which need to activate CD4+ T cells [33] , or SPM induces different pattern of cytokine production from SEs and SPEA to induce CD4+ T cell proliferation preferentially due to different affinity to MHC molecule or VB of TCR [34] .
In conclusion, our study demonstrates the isolation of a new superantigen with potent mitogenic activity to not only human but also murine T cells from S. pyogenes. Recently, it was indicated that most of the streptococcal infectious diseases or postinfectious sequelae might be attributed to the active response of T cells stimulated with streptococcal superantigens, although molecular mechanism of the superantigens involved in the pathogenesis in vivo has to be elucidative [1, 2] . We consider that SPM might be useful to elucidate the precise mechanism of streptococcal infectious diseases possibly caused by superantigens in experimental murine model in vivo.
